Suppr超能文献

《安全医疗器械法案》:医院遵守美国食品药品监督管理局新要求的管理指南

Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.

作者信息

Alder H C

出版信息

Hosp Technol Ser. 1993 Oct;12(11):1-27.

Abstract

The Safe Medical Devices Act of 1990 (Public Law 101-629) was signed by President George Bush almost three years ago on November 28, 1990. The law expanded the Food and Drug Administration's (FDA) authority to regulate medical devices and grew out of congressional concerns about the FDA's ability to quickly learn when a medical device caused an adverse patient event, and to ensure that hazardous devices are removed from hospitals and other health care facilities in a timely manner. The Safe Medical Devices Act is an extension of the Medical Device Amendments of 1976, which imposed production, distribution, and sales rules on medical device manufacturers. It gives the FDA the legal authority to directly regulate the use of medical devices in health care facilities. Among the Safe Medical Devices Act's provisions are specific requirements for hospitals, health professionals, and other users of medical devices to report patient incidents involving medical devices to the manufacturer and to the FDA if a device caused or contributed to a serious injury, death, or other "adverse experience." Adverse experiences are defined by the FDA to include concussions, fractures, burns, temporary paralysis, and temporary loss of sight, hearing, or smell. Hospitals have been required to comply with this provision of the law, called user reporting, since 1991. Hospitals are also required to participate in tracking certain medical devices whose failure could result in a serious adverse health outcome. The law requires distributors and manufacturers of specific devices to adopt a method for device tracking. Hospitals are required to cooperate with and provide device manufacturers with information about patients with permanently implantable devices and life-sustaining and life-supporting devices used outside device user facilities. The law also gives the FDA the authority to designate other devices subject to tracking if the agency determines such tracking is warranted to preserve the patient's health. This provision of the law is called device tracking. Device tracking became effective on August 29, 1993. This special report addresses some of the major questions about implementing user reporting and device tracking in hospitals. Over the past two years the FDA has issued a series of rules and regulations that have caused a great deal of confusion and misunderstanding. Some of the law's provisions are straightforward; however, some basic issues and rules--such as the definition of a reportable event--are unclear. While there are still some open questions about the reporting and tracking requirements, the following is the best information available at this time.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

1990年的《安全医疗器械法案》(公法101 - 629)由乔治·布什总统于近三年前,即1990年11月28日签署。该法律扩大了食品药品监督管理局(FDA)对医疗器械的监管权力,源于国会对FDA能否迅速了解医疗器械何时导致患者不良事件,以及确保危险器械及时从医院和其他医疗保健机构移除的担忧。《安全医疗器械法案》是1976年《医疗器械修正案》的延伸,后者对医疗器械制造商施加了生产、分销和销售规则。它赋予FDA直接监管医疗保健机构中医疗器械使用的法律权力。《安全医疗器械法案》的条款包括对医院、医疗专业人员和其他医疗器械使用者的具体要求,即如果器械导致或促成严重伤害、死亡或其他“不良事件”,需向制造商和FDA报告涉及医疗器械的患者事件。FDA将不良事件定义为包括脑震荡、骨折、烧伤、暂时瘫痪以及视力、听力或嗅觉的暂时丧失。自1991年以来,医院一直被要求遵守这项法律规定,即用户报告。医院还被要求参与追踪某些医疗器械,其故障可能导致严重的不良健康后果。该法律要求特定器械的经销商和制造商采用器械追踪方法。医院必须与器械制造商合作,并向其提供有关使用永久植入式器械以及在器械用户设施外使用的维持生命和支持生命器械的患者信息。如果FDA确定此类追踪对于保护患者健康是必要的,该法律还赋予FDA指定其他需追踪器械的权力。这项法律规定称为器械追踪。器械追踪于1993年8月29日生效。本特别报告探讨了在医院实施用户报告和器械追踪的一些主要问题。在过去两年中,FDA发布了一系列规则和条例,造成了大量的混乱和误解。该法律的一些条款很直接;然而,一些基本问题和规则——如可报告事件的定义——并不明确。虽然关于报告和追踪要求仍有一些未解决的问题,但以下是目前可得的最佳信息。(摘要截至于400字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验